| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_153ae69eed34c3caf715379b30dd185f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_49f09cdb7e0d01a30b042761d251c896
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d40960190e37af1e3390c21a67554f98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_80ea52df622383c2e8bba7e16c3787e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e75c035c039de44304823b8b779640c |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74 |
| filingDate |
2005-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2007-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e1fdc687630de7c7d38aa46d2edf2d8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c724a7f9766dfe6bec560f9434ab2724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e22f9fd66ad2c519eb06d6ccfa982ed3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_847bf471af8f5d3966cfd6469d30dc44 |
| publicationDate |
2007-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2300109-C2 |
| titleOfInvention |
Method for predicting cerebral metastasis lesion foci in metastatic brain injury patients |
| abstract |
FIELD: medicine. n SUBSTANCE: method involves determining thyroxin hormone concentration in cerebral metastasis-ill patient blood prior to treatment beginning. Its concentration being found within the limits of 68.0-115.0 nmole/l, 1 to 3 metastatic lesion foci are predicted to be available. The concentration being from 38.0 to 50.0 nmole/l, more than 4 p metastatic lesion foci are predicted to be available. n EFFECT: high forecasting accuracy both in primary examination period, and when carrying out treatment. n 1 tbl |
| priorityDate |
2005-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |